Feature: Superclick Sales Soar. Russell Microcap Index to Debut.

Sep 18, 2021

/

12:41 AM PST

Rating

No ratings

Feature: Superclick Sales Soar. Russell Microcap Index to Debut. This Friday, the Russell family of indices will add the Russell Microcap Index. I'm excited. It looks pretty darned nifty. Expect there will be an Exchange Traded Fund (ETF) based on it, bu
Feature: Intel - Sold it. Bought it. Holding it.

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Feature: Intel - Sold it, Bought it, Holding it. On August 12th 2004, we reversed our longstanding dislike of Intel (NASDAQ: INTC) when the shares hit $21.24. Previously we had disliked it at $34 and $28 as overvalued and over-hyped by analysts who told
Feature: Bio Advances - Biophan, MIV Therapeutics. Stream's Revenue

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Feature: Bio Advances - Biophan, MIV Therapeutics. Stream's Revenue Flows. Biophan (OTCBB: BIPH) CEO Michael Weiner recently stated: "There is no longer any excuse for not making and certifying devices to be safe with MRI machines." And he should know. B
Feature: Biocurex's RECAF Marker - The World is Waiting.

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Feature: BioCurex's RECAF Marker - The World is Waiting. For several days in September, in Rhodes Greece, the elite of the oncology community--academia and industry--will gather at the 33rd congress of the International Society of Oncodevelopmental Biolo
Feature: Biocurex Expands RECAF Technologies.

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Feature: BioCurex Expands RECAF Technologies. As we noted in our May 11th article, BioCurex (BOCK.PK) is expanding its cancer imaging and therapy technology focus. With the announcement (release below) of a collaboration with the Goshen, Indiana-based Ce
<<290  291  292  293  294  295  296  297  298  299  >>